These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28382805)

  • 1. Drug eluting stents and modern stent technologies for in-stent restenosis.
    Werner M
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):497-500. PubMed ID: 28382805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-stent restenosis management: the best is yet to come.
    van den Berg JC
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):508-517. PubMed ID: 28322039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography: guided therapy of in-stent restenosis for peripheral arterial disease.
    Lichtenberg MK; Carr JG; Golzar JA
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):518-527. PubMed ID: 28382804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.
    Murata N; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Yokoi H; Tosaka A; Tanaka N; Iida O
    J Endovasc Ther; 2016 Aug; 23(4):642-7. PubMed ID: 27099284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting stents above the knee.
    Minar E
    J Cardiovasc Surg (Torino); 2011 Apr; 52(2):225-9. PubMed ID: 21460772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
    Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
    J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of drug-coated balloons in in-stent restenosis.
    Andrassy M; Celik S; Andrassy J; Lichtenberg MK; Brodmann M
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):501-507. PubMed ID: 28358184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for treatment of lower limb in-stent restenosis with drug eluting balloons.
    Li BH; Chan YC; Cheng SW
    J Cardiovasc Surg (Torino); 2020 Oct; 61(5):626-631. PubMed ID: 33231030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Femoropopliteal in-stent restenosis: current treatment strategies.
    Singh GD; Armstrong EJ; Laird JR
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):325-33. PubMed ID: 24755700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of in-stent restenosis in peripheral arteries: are DEBs sufficient as stand-alone treatment for femoro-popliteal in-stent restenosis?
    Franzone A; Stabile E; Carbone A; Scudiero F; Trimarco B; Esposito G
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):335-8. PubMed ID: 24755701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which is currently the best strategy for treatment of SFA in-stent restenosis?
    Elens M; Verbist J; Keirse K; Van Den Eynde W; Peeters P
    J Cardiovasc Surg (Torino); 2014 Aug; 55(4):477-81. PubMed ID: 24941234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of mechanical atherectomy and drug-eluting balloons for femoropopliteal in-stent restenosis.
    Beschorner U; Zeller T
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):347-9. PubMed ID: 24755703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents.
    Zeller T; Dake MD; Tepe G; Brechtel K; Noory E; Beschorner U; Kultgen PL; Rastan A
    JACC Cardiovasc Interv; 2013 Mar; 6(3):274-81. PubMed ID: 23517839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sense and nonsense of bare metal stents below the knee.
    Caradu C; Brizzi V; Auque H; Midy D; Ducasse E
    J Cardiovasc Surg (Torino); 2016 Oct; 57(5):653-66. PubMed ID: 27177357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stents below the knee.
    Bosiers M; Deloose K; Callaert J; Keirse K; Verbist J; Peeters P
    J Cardiovasc Surg (Torino); 2011 Apr; 52(2):231-4. PubMed ID: 21460773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrainguinal disease treatment: to stent or not to stent.
    Dosluoglu H; Lall P
    J Cardiovasc Surg (Torino); 2011 Oct; 52(5):701-16. PubMed ID: 21894138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Eluting vs Standard Balloon Angioplasty for Iliac Stent Restenosis: Midterm Results.
    Stahlhoff S; Donas KP; Torsello G; Osada N; Herten M
    J Endovasc Ther; 2015 Jun; 22(3):314-8. PubMed ID: 25991767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.